Skip to content

Drug interactions

Ipratropium-salbutamol + Lenvatinib

Severity: Moderate

Ipratropium-salbutamol and Lenvatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenvatinib can prolong the QT interval and cause electrolyte disturbances, and salbutamol may add to this risk through hypokalemia and cardiac stimulation. The combination may increase arrhythmia risk in vulnerable patients.

What this interaction means in plain words

Ipratropium-salbutamol and Lenvatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ipratropium-salbutamol belongs to Respiratory; Lenvatinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive QT prolongation, with beta-agonist-induced hypokalemia.

What to do

Monitor ECG and correct potassium, magnesium and calcium abnormalities during lenvatinib therapy. Limit salbutamol to what is clinically needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Lenvatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ipratropium-salbutamol with Lenvatinib?

MediHelp rates the interaction as moderate. Ipratropium-salbutamol and Lenvatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenvatinib can prolong the QT interval and cause electrolyte disturbances, and salbutamol may add to this risk through hypokalemia and cardiac stimulation. The combination may increase arrhythmia risk in vulnerable patients.

How serious is the interaction between Ipratropium-salbutamol and Lenvatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and correct potassium, magnesium and calcium abnormalities during lenvatinib therapy. Limit salbutamol to what is clinically needed.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in